Nemluvio demonstrated long-term improvements in itch intensity, skin lesions and quality of life The OLYMPIA LTE study was designed to assess the safety and efficacy of Nemluvio in patients with ...
With the BLA for the same compound in atopic dermatitis (AD) accepted for review by the U.S. FDA, Galderma Holding SA scored clearance from the agency of Nemluvio (nemolizumab) as a prefilled pen for ...
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226796734/en/ “Prurigo nodularis is not only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results